‘Multiple medicines’ side-effect risk for over-65s

Two million older people are risking side-effects from taking multiple medications, a charity warns.

Share Button

Health24.com | People living in tree-filled suburbs have better mental wellbeing

City dwellers who live on tree-lined streets might be happier and healthier for it, a large new study suggests.

The study, of nearly 47 000 urban residents, found that those who lived in areas shaded by tree canopy reported less psychological distress and better general health over six years.

Trees are health-promoting

Green grass, on the other hand, didn’t cut it: People in neighbourhoods with more grassy areas actually reported poorer health than those largely surrounded by concrete.

The researchers said the findings suggest there might be something particularly health-promoting about trees. Maybe people who have them nearby have more chances for walking and recreation, or enjoy a buffer against noise and traffic pollution, for example.

The bottom line: Trees seem to matter to our well-being, said Kathleen Wolf, a research social scientist at the University of Washington’s College of the Environment, in Seattle.

Wolf, who was not involved in the study, said it adds to a body of research finding a link between “green space” and better health.

A UK study published last month is a case in point. It found that people who spent two hours a week outdoors gave higher ratings to their physical and mental health than those who preferred the great indoors.

“If you have one study showing an association,” Wolf said, “it gives you a heads-up – ‘Hey, this is an interesting finding.'”

Fewer distress symptoms

When multiple studies show the same pattern, it suggests something is really there, she added.

A strength of the new study is that it followed people over time, Wolf said, rather than measuring well-being only once.

On average, it found, city dwellers who lived near more tree canopy were less likely to develop new symptoms of psychological distress – like nervousness, hopelessness and unexplained fatigue.

The benefit was seen among people living in areas with tree coverage of least 30% within a mile of home. Compared with residents with few nearby trees, they were about one-third less likely to report distress symptoms on a standard questionnaire.

They were also one-third less likely to downgrade ratings of their general health to “fair” or “poor”.

Of course, there could be many things about living in greener areas that make people happier and healthier. But the researchers tried to account for those differences – weighing factors like household income, education levels and marital status.

A better sense of perspective

Even then, trees still mattered to mental and physical well-being.

Why would that be? Wolf pointed to various possibilities. Tree-lined streets and parks may give people more opportunities for exercise – which, she noted, is important not only for physical well-being, but mental health, too.

There’s also a theory that being out in nature offers a better sense of perspective, which makes our daily stresses seem less significant.

“Human beings tend to ruminate on the bad things that happen, rather than the good,” Wolf said. Some of that mental playback may fade when you’re outdoors, with things to see, smell and experience, she noted.

Living near grassy surroundings, on the other hand, was linked to higher odds of distress and poor health.

The study cannot reveal why, said Sjerp de Vries, a researcher with Wageningen University and Research in the Netherlands. But, he said, unlike grass, trees can make an area more walkable.

Boosting immune function

Trees are also more obvious, de Vries said. Tall trees, especially, make their presence known whether people are outside or inside.

Plus, de Vries noted, there is an argument to be made that trees are beneficial because they release chemicals called phytoncides, which may boost human immune function.

He wrote an editorial accompanying the new study, which was published online in JAMA Network Open.

The study results were based on 46 786 adults aged 45 and older in three large Australian cities. All remained in the same neighbourhood over six years, and completed the same health questionnaires at the beginning and end of the study period.

It’s possible, de Vries said, that healthier people chose to live in tree-lined areas. But other studies have suggested that “green space” has particular benefits for lower-income people, he noted. And they have less choice about where to live than their wealthier counterparts.

Image credit: iStock

NEXT ON HEALTH24X

Share Button

Health24.com | When is it time for seniors to hand over the car keys?

Driving is a source of independence for many seniors, so determining when they should hang up the keys requires careful consideration, an expert says.

“Driving retirement is a normal part of ageing, and should be carefully considered and discussed openly,” said Dr Ericka Tung, an internist and geriatrician at the Mayo Clinic in Rochester, Minnesota.

No single test

“Primary care providers are uniquely poised to counsel patients about driving safety because they understand their patients’ health conditions, capacities, challenges and goals,” Tung said in a clinic news release. She is lead author of a paper in the journal Mayo Clinic Proceedings that examines the issue.

There’s no single test to determine whether an older person should continue driving, but health care providers can look at several areas of physical and mental functioning to assess a senior’s driving fitness.

Those areas are vision, including depth perception and visual fields; thinking skills, including changes in memory, attention or language; mobility and physical function, including range of motion and coordination of the neck, upper body and lower body; health conditions that could affect the ability to safely operate a vehicle, and medications that could impair alertness.

Another key factor is input from family members or other care providers, according to Tung and her colleagues.

Open dialogue encouraged

These people can provide information about the senior’s driving performance, ability to do daily basic tasks of living, or their history of falls. All can help determine if the senior needs a driver safety refresher course or should stop driving.

Because driving gives many seniors a sense of independence and control, any decision about hanging up their car keys must be communicated clearly and with compassion, the authors said.

It’s critical that seniors stop driving at the appropriate time – not after they’ve had a crash.

“Open dialogue is encouraged between patients, families and primary care teams to ensure safety on the road,” Tung said.

Image credit: iStock

Share Button

Evidence suggests microplastics in water pose ‘minimal health risk’

The World Health Organization says its findings are based on the “limited information” available.

Share Button

Health24.com | Scientists creating gene map of human ‘microbiome’

The number of genes in bacteria that live in and on people could top 1 billion trillion – and at least half appear to be unique to their host.

That mindboggling math comes from scientists at Harvard Medical School and Joslin Diabetes Center in Boston who have set out to map all genes of the human microbiome.

A gateway study

The research could reveal links between microbiome genes and human disease, and lead to development of precision treatments, they said.

So far, researchers have analysed the genes of bacteria in the human mouth and gut. Those findings were published in the journal Cell Host & Microbe.

“Ours is a gateway study, the first step on what will likely be a long journey toward understanding how differences in gene content drive microbial behaviour and modify disease risk,” said study first author Braden Tierney, a graduate student at Harvard Medical School.

The diversity of genes is far greater than researchers expected. They said the functions of microbial genes unique to each person are different from those of shared genes.

The team analysed more than 2 100 bacteria samples from people’s guts and more than 1 400 from their mouths. The samples contained nearly 46 million bacterial genes – about 24 million from the mouth and 22 million in the gut.

Trillions of bacteria

More than half of the bacterial genes (23 million) occurred only once, meaning they were unique to the individual. Of those unique genes, 11.8 million came from the mouth and 12.6 million from the gut.

The human microbiome contains trillions of bacteria. Most are harmless, many beneficial, but some cause disease. There is growing evidence that these microbes play an important role in health.

Changes in levels and types of bacteria in and on your body have been linked to development of conditions ranging from tooth decay to diabetes, chronic inflammatory bowel disease and multiple sclerosis, the study authors noted.

So far, most research has focused on how various types of bacteria might affect disease risk. By contrast, this new research analyses the genes in these bacteria.

Study co-senior author Chirag Patel said that “just like no two siblings are genetically identical, no two bacterial strains are genetically identical, either”. Patel is an assistant professor of biomedical informatics at Harvard Medical School.

“Two members of the same bacterial strain could have markedly different genetic makeup, so information about bacterial species alone could mask critical differences that arise from genetic variation,” he explained in a Harvard news release.

Valuable clues

Learning more about the genes in these bacteria could lead to precisely targeted treatments, according to study senior co-author Alex Kostic. He’s an assistant professor of microbiology at Harvard and an investigator at the Joslin Diabetes Center.

“Such narrowly targeted therapies would be based on the unique microbial genetic make-up of a person rather than on bacterial type alone,” Kostic said.

Profiling these unique genes could provide valuable clues about past exposures to different pathogens or environmental influences, as well as disease risk, he concluded.

Image credit: iStock

Share Button

Fish oil pills ‘no benefit’ for type 2 diabetes

People with type 2 diabetes “should not be encouraged” to take omega-3, researchers say.

Share Button

Mashed potatoes: Cut the fat

Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.

Advertising & Sponsorship

Mayo Clinic Marketplace

Check out these best-sellers and special offers on books and newsletters from Mayo Clinic.

Share Button

Scientists propose network of imaging centers to drive innovation in biological research

When sparks fly to innovate new technologies for imaging life at the microscopic scale, often diverse researchers are nudging each other with a kind of collegial one-upmanship.

“Look at the resolution we obtain with this microscope I’ve designed,” the physicist says. “Great,” the biologist replies, “but my research organism moves fast. Can you boost the system’s speed?” “You’ll have terabytes of raw data coming off that microscope system,” says the computational scientist. “We’ll build in algorithms to manage the data and produce the most meaningful images.” Around they go, propelling a cycle of challenge and innovation that allows them to see more clearly into new dimensions of the microscopic world.

Interdisciplinary interactions are essential for driving the innovation pipeline in biological imaging, yet collegial workspaces where they can spring up and mature are lacking in the United States. Last fall, the Marine Biological Laboratory (MBL) convened a National Science Foundation workshop to identify the bottlenecks that stymie innovation in microscopy and imaging, and recommend approaches for transforming how imaging technologies are developed and deployed. The conclusions of the 79 workshop participants are summarized in a Commentary in the August issue of Nature Methods.

“We propose a network of national imaging centers that provide collaborative, interdisciplinary spaces needed for the development, application, and teaching of advanced biological imaging techniques,” write the authors and workshop leaders, MBL Fellows Daniel A. Colón-Ramos of Yale University School of Medicine, Patrick La Riviere of the University of Chicago, Hari Shroff of the National Institute of Biomedical Imaging and Bioengineering, and MBL Senior Scientist Rudolf Oldenbourg.

“Creating spaces for co-locating microscopists, computational scientists and biologists, in our experience, is a key and missing ingredient in new and necessary ecosystems of innovation. Sometimes the seeds of innovation have to be planted in the same pot for them to flower and be fruitful,” Colón-Ramos says.

For the proposed centers to optimally succeed, they need expert staff scientists who engage in and catalyze collaborations among the major players in the imaging ecosystem, the group concluded. The centers will provide space and expertise not only for teaching existing, high-end imaging techniques, but also for designing and testing new technologies with real-world biological applications and disseminating them promptly to staff and visiting scientists, faculty and students. All can participate in an iterative innovation process, driving discovery while becoming interdisciplinary thinkers and project developers themselves.

As a next step in transforming the vision of national imaging centers into a reality, a follow-up meeting with a variety of funding stakeholders will be scheduled in the spring of 2020. 

An Imaging Initiative is in progress at the MBL, with many elements of the proposed national imaging centers already in place and others under development.

Story Source:

Materials provided by Marine Biological Laboratory. Note: Content may be edited for style and length.

Share Button

Parasite needs chemical (lipid/nutrient) in cat intestines for sex

Toxoplasma gondii is a microbial parasite that infects humans and but needs cats to complete its full life cycle. New research published August 20 in the open-access journal PLOS Biology shows why: the sexual phase of the parasite’s life cycle requires linoleic acid, a nutrient/lipid found at uniquely high levels in the felines, because cats lack a key enzyme for breaking it down. The finding, from by Bruno Martorelli Di Genova and Laura Knoll of the University of Wisconsin-Madison and colleagues, is likely to help in the development of treatments to reduce spread of the parasite from cats to their human companions. It also presents an opportunity to avoid using cats for Toxoplasma research.

Toxoplasma can live asexually in any mammal, including humans. But it forms gametes (sexual cells) only in cats, a restriction that has long been recognized, but whose reason was not understood. The authors suspected something was missing when reproducing the infections in vitro and not observing sexual development. It is known that fungi require linoleic acid for sexual development. To test Toxoplasma’s requirement for the same lipid, they generated cat intestinal organoids — three-dimensional “test tube” models that share several essential properties with actual intestines — and showed that linoleic acid was required for sexual reproduction of the parasite. Cats lack an enzyme called delta-6-desaturase, which catalyzes the conversion of linoleic acid to arachidonic acid, accounting for the peculiarly high levels of linoleic acid in the cat intestine, but not in other mammals. When the authors supplemented the diet of mice with linoleic acid, and added a specific inhibitor of the enzyme, Toxoplasma could complete the sexual phase of its life cycle in the mouse intestine.

Toxoplasma is the leading cause of foodborne illness in the US, according to CDC. The most common route of infection for human is by consumption of contaminated raw or undercooked meat. Cat litter, after 24-48 of being cleaned, can also a source of Toxoplasma infection. However, cats can only shed oocysts once in their life time. Pregnant women are urged to avoid eating raw or undercooked meat, as also avoiding cleaning the litterbox after 48 hours, to prevent Toxoplasma infection. Congenital toxoplasmosis can have potentially serious consequences for the unborn child. An improved understanding of the parasite life cycle stemming from this study may lead to production of vaccines that could inhibit Toxoplasma’s sexual reproduction or the transmission of Toxoplasma to livestock.

Story Source:

Materials provided by PLOS. Note: Content may be edited for style and length.

Share Button

New pharmaceutical target reverses osteoporosis in mice

 Biomedical engineers at Duke University have discovered a pharmaceutical target that, when activated, can reverse bone degradation caused by osteoporosis in mouse models of the disease.

“The most widely used drugs currently approved by the FDA to treat osteoporosis can prevent further bone loss, but they don’t help rebuild the bone,” said Shyni Varghese, professor of biomedical engineering, mechanical engineering and materials science, and orthopedics at Duke.

“We’ve discovered a biochemical receptor that, when activated, can do both,” added Yu-Ru “Vernon” Shih, a research scientist in Varghese’s lab and the study’s first author.

The findings appear online August 21 in the journal Science Advances.

Despite its apparent rigidity, bone is living tissue constantly being broken down and replaced by the body. Osteoporosis occurs when old tissue is lost faster than new tissue can be created, causing the bone to become weak and brittle. The disease afflicts more than 40 million men and women in the United States alone and is most common in older women past menopause.

In 2014, Varghese was studying the role of popular biomedical devices made of calcium phosphate in promoting bone repair and regeneration. She discovered that the biochemical adenosine acting on the A2B receptor plays a particularly large role in promoting bone growth. It stood to reason that a lack of the chemical might play a role in the development of osteoporosis, so Varghese decided to find out.

In the study, Varghese and her research team studied mice that had had their ovaries removed to mimic post-menopause osteoporosis. They looked at the expression levels of two enzymes that help produce adenosine as well as the levels of adenosine traveling between cells. As predicted, they discovered that the mice’s lack of estrogen was causing all three to plummet.

The researchers then tested to see if increasing the levels of adenosine in the mice would help reverse the damaging effects of the disease. But rather than pumping in adenosine itself, they injected a non-hormonal small molecule produced by Bayer that activates the A2B receptor.

“The mice that received the drug were completely cured,” said Varghese. “Their bones were just as healthy as the control group without osteoporosis.”

While the discovery of a pharmaceutical target capable of reversing osteoporosis is exciting, creating a small molecule drug that can activate it without side effects is a difficult task. Adenosine is created naturally throughout the entire body and has many roles such as modulating neurons and regulating blood flow to various organs. Researchers can’t simply dump a bunch of it into the bloodstream to stop bone degradation without side effects.

But with the A2B receptor identified, Varghese and others can start looking for ways to deliver activators to bones without flooding other areas of the body. For example, one of Varghese’s students is beginning to study ways of tethering adenosine-like molecules to carriers that target bone tissue. Her lab is also pursuing a sort of bandage that can deliver growth-supporting drugs directly to damaged or broken bones.

This research was supported by the National Institutes of Health (R01-AR063184, R01-AR071552).

Story Source:

Materials provided by Duke University. Note: Content may be edited for style and length.

Share Button